← Back to patent-cliff list
Mycophenolic Acid/Betamethasone Sodium Phosphate
Tier C — Watch / tradeMycophenolic Acid/Betamethasone Sodium Phosphate
Surface Ophthalmics Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：IMPDH, GR
Indications (approved)：Dry eye syndrome
Regional status
US
Phase II
2021-01-11
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Mycophenolic Acid/Betamethasone Sodium Phosphate?
Approved indications include: Dry eye syndrome.
When does the Mycophenolic Acid/Betamethasone Sodium Phosphate patent expire?
No public expiry year is available for Mycophenolic Acid/Betamethasone Sodium Phosphate yet; this page updates once verified.
How do I get a quote for Mycophenolic Acid/Betamethasone Sodium Phosphate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06